LYMPHATIC FILARIASIS: THE BURDEN, THE PROMISE
The infection is usually acquired in childhood. Its most dreaded
consequences are elephantiasis (massive swelling of the arms,
legs, breasts and genitals) and hydrocele (fluid-filled swelling
of the scrotum), both of which effectively destroy an affected individual's
quality of life.
The infection also leads to episodes of debilitating fever and enormous pain.
The deep creases of swollen legs and feet provide a perfect environment for
incapacitating secondary bacterial infections.
For many suffering from LF, the psychological toll is as devastating
as the physical symptoms. So discomfited by the disfigurement
(the scrotums of men can swell to the size of basketballs
or larger), affected individuals often cease to go out in public
and become reclusive.
Even beyond the physical and psychological toll, the disease
creates severe economic burden. Infected men and
women frequently cannot work or take care of their
families. To help earn money for the family, children may drop out of school, sharply
reducing their future earning potential. LF infection entrenches
entire families in poverty.
Community-wide treatment is based on the
co-administration of two safe and effective oral
anti-parasite drugs, given to members of at-risk
communities. The standard treatment is albendazole
with either Mectizan®
(ivermectin) or DEC (diethylcarbamazine), depending on local
conditions, taken just once a year.
Through the generosity of
GlaxoSmithKline and
Merck & Co., Inc. albendazole
and Mectizan® are donated free of charge;
DEC is a widely-used and very inexpensive medicine.
While the drug regimen is seemingly simple - single doses
of two medicines once a year for four to six years or table
salt fortified with DEC - the logistics of providing treatment
to all of the over one billion people at risk is an enormously complex
challenge! Ensuring that all individuals at risk of infection,
often in areas remote and difficult to access, are identified
and treated requires a high degree of technical expertise.
The effort to achieve this goal is known as the
Global Programme to Eliminate Lymphatic Filariasis.
Coordinated by the
World Health Organization, it is
supported by a Global Alliance of public, private,
and international institutions, each contributing its own
special expertise.
LFSC Publications | Resources | LF Links | LFSC Staff | Contact Us | What's New
|